Home › NDC Lookup › RxCUI directory › RxCUI 104208

2 ML digoxin 0.25 MG/ML Injection — RxCUI 104208

Name: 2 ML digoxin 0.25 MG/ML Injection (RxCUI 104208)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 104208 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI104208

Official name2 ML digoxin 0.25 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asdigoxin 500 MCG per 2 ML Injection; digoxin 500 MCG in 2 ML Injection

FDA products mapped12

Package NDCs mapped11

Reported Medicaid activity (SDUD)189 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Digoxin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Digoxin is being used for one of two main reasons: either to help your heart pump more effectively in heart failure, or to slow down a fast heart rate caused by atrial fibrillation...
Why did my doctor prescribe digoxin — what is it actually doing for me?
The most important ones to call your doctor about are nausea, vomiting, loss of appetite, unusual vision changes (like seeing a yellow-green tint or halos around lights), dizziness...
What side effects should I actually watch out for?

📖 Read our full Digoxin guide →

🕸️ Concept Web — How 2 ML digoxin 0.25 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2 ML digoxin 0.25 MG/ML Injection RxCUI 104208 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Digoxin 3407 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Lanoxin 202988 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Digoxin Injection 1743558 SCDF
- Digoxin Injectable Product 1151519 SCDG
- Digoxin Injection [Lanoxin] 1743560 SBDF
- Lanoxin Injectable Product 1175613 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Digoxin 0.25 MG/ML 315822 SCDC
- 2 ML digoxin 0.25 MG/ML Injection [Lanoxin] 208137 SBD
- Digoxin 0.25 MG/ML [Lanoxin] 568863 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Digoxin 0.25 MG/ML SCDC · 315822
Digoxin Injection SCDF · 1743558
Digoxin Injectable Product SCDG · 1151519

Brand-Name Concepts

2 ML digoxin 0.25 MG/ML Injection [Lanoxin] SBD · 208137
Digoxin 0.25 MG/ML [Lanoxin] SBDC · 568863
Digoxin Injection [Lanoxin] SBDF · 1743560
Lanoxin Injectable Product SBDG · 1175613
Lanoxin BN · 202988

📦 FDA Products & Package NDCs

12 products · 11 package NDCs

11 package NDCs map to RxCUI 104208 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00404-9850-02	1 AMPULE in 1 BAG (0404-9850-02) / 2 mL in 1 AMPULE	Digoxin	Henry Schein, Inc.	2022-01-10
00641-1410-35	25 AMPULE in 1 CARTON (0641-1410-35) / 2 mL in 1 AMPULE (06...	Digoxin	Hikma Pharmaceuticals USA Inc.	1975-10-24
00641-6184-25	25 AMPULE in 1 CARTON (0641-6184-25) / 2 mL in 1 AMPULE (06...	Digoxin	Hikma Pharmaceuticals USA Inc.	1975-10-24
00781-3059-95	10 AMPULE in 1 CARTON (0781-3059-95) / 2 mL in 1 AMPULE (07...	Digoxin	Sandoz Inc	2003-08-21
51662-1217-01	2 mL in 1 AMPULE (51662-1217-1)	DIGOXIN	HF Acquisition Co LLC, DBA HealthFirst	2018-09-13
51662-1217-03	25 POUCH in 1 CASE (51662-1217-3) / 1 mL in 1 POUCH (51662-...	DIGOXIN	HF Acquisition Co LLC, DBA HealthFirst	2021-01-12
55154-5106-05	5 AMPULE in 1 BAG (55154-5106-5) / 2 mL in 1 AMPULE	Digoxin	Cardinal Health 107, LLC	2011-06-28
70515-0261-10	10 VIAL in 1 BOX (70515-261-10) / 2 mL in 1 VIAL	LANOXIN	Covis Pharma US, Inc	2019-10-29
70515-0263-10	10 VIAL in 1 BOX (70515-263-10) / 1 mL in 1 VIAL	LANOXIN	Covis Pharma US, Inc	2019-10-29
71872-7325-01	1 AMPULE in 1 BAG (71872-7325-1) / 2 mL in 1 AMPULE	Digoxin	Medical Purchasing Solutions, LLC	2024-05-29
84549-0410-35	2 mL in 1 AMPULE (84549-410-35)	Digoxin	ProPharma Distribution	2025-12-11

Observed labelers: Covis Pharma US, Inc (2) · HF Acquisition Co LLC, DBA HealthFirst (2) · Hikma Pharmaceuticals USA Inc. (2) · Cardinal Health 107, LLC (1) · Henry Schein, Inc. (1) · Medical Purchasing Solutions, LLC (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1160	Digoxin injection	8	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.